Skip to main content
OpenTrials

Clinical trial condition

Epileptic Encephalopathy

Explore clinical trials studying Epileptic Encephalopathy. Study availability and eligibility vary by location and protocol.

9 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Epileptic Encephalopathy trial results

Recruiting

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

NCT07019922

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +7 more
Locations
  • Praxis Research Site San Diego, California, United States
  • Praxis Research Site Aurora, Colorado, United States
  • Praxis Research Site Chicago, Illinois, United States
  • Praxis Research Site Cincinnati, Ohio, United States
View Trial Details
Recruiting

A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy

NCT07227857

Conditions
Epileptic Encephalopathy
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

NCT06855901

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, +5 more
Locations
  • Ospedale pediatrico Bambino Gesù Roma, Italy
  • Azienda Sanitaria Universitaria Giuliano Isontina Trieste, Italy
  • S.S.D. Neurofisiologia Clinica - AOU di Modena Modena, Taly, Italy
  • Azienda Ospedaliero Universitaria Federico II - Napoli Naples, Taly, Italy
View Trial Details
Completed

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT03936777

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Ep0215 107 Tucson, Arizona, United States
  • Ep0215 144 Los Angeles, California, United States
  • Ep0215 108 San Diego, California, United States
  • Ep0215 101 San Francisco, California, United States
View all 71 locations
View Trial Details
Completed

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

NCT04625101

Conditions
Continuous Spike and Wave During Sleep, Epileptic Encephalopathy
Locations
  • Neurocrine Clinical Site Orange, California, United States
  • Neurocrine Clinical Site Aurora, Colorado, United States
  • Neurocrine Clinical Site Washington D.C., District of Columbia, United States
  • Neurocrine Clinical Site Miami, Florida, United States
View all 15 locations
View Trial Details

Related conditions